Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tropocells PRP

PreclinicalSmall molecule

MMedical University of Lodz

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2026

Injury

NCT06631976

Clinical

Trials by Indication[1]

Injury1 trial

Conservative Treatment in Patients With Supraspinatus Tendon Injury.

Recruiting·MMedical University of Lodz·N/A·NCT06631976·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tropocells PRP. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tropocells PRP compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tropocells PRP. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medical University of Lodz company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMedical University of Lodz

Related News